Citation Impact
Citing Papers
Endogenous MHC Class II Processing of a Viral Nuclear Antigen After Autophagy
2004 Science
Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
2010 StandoutNobel
Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8
2004 StandoutScience
Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins
2006
Uracil DNA Glycosylase Activity Is Dispensable for Immunoglobulin Class Switch
2004 StandoutScienceNobel
Interferon- γ Control of EBV-Transformed B Cells: A Role for CD8 + T Cells That Poorly Kill EBV-Infected Cells
2002
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
2017 StandoutNature
The promise and challenge of therapeutic genome editing
2020 StandoutNatureNobel
mRNA Is an Endogenous Ligand for Toll-like Receptor 3
2004 StandoutNobel
Biology and adoptive cell therapy of Epstein‐Barr virus‐associated lymphoproliferative disorders in recipients of marrow allografts
1997
Autophagy fights disease through cellular self-digestion
2008 StandoutNature
Autophagy in innate and adaptive immunity against intracellular pathogens
2006
Dendritic cells: versatile controllers of the immune system
2007 StandoutNobel
A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity
2008 StandoutNature
Lamp-2a Facilitates MHC Class II Presentation of Cytoplasmic Antigens
2005
Pathogenic roles for Epstein–Barr virus (EBV) gene products in EBV-associated proliferative disorders
2002
Dendritic Cells Expand Epstein Barr Virus Specific CD8+ T Cell Responses More Efficiently Than EBV Transformed B Cells
2005 StandoutNobel
Antigen presentation to CD8+ T cells: cross-priming in infectious diseases
2001
CD4 and CD8 T cell responses to tumour-associated Epstein–Barr virus antigens in nasopharyngeal carcinoma patients
2007
Low‐avidity recognition by CD4 + T cells directed to self‐antigens
2003
Immunogenicity of induced pluripotent stem cells
2011 StandoutNature
Innate and Adaptive Immunity through Autophagy
2007
A minimal glycine-alanine repeat prevents the interaction of ubiquitinated IκBα with the proteasome: a new mechanism for selective inhibition of proteolysis
1998
Functional Inactivation of EBV-Specific T-Lymphocytes in Nasopharyngeal Carcinoma: Implications for Tumor Immunotherapy
2007
Central roles of NLRs and inflammasomes in viral infection
2010
Cross-Presentation of Cell-Associated Antigens by Dendritic Cells
2003
Epstein-Barr Virus Transactivates the Human Endogenous Retrovirus HERV-K18 that Encodes a Superantigen
2001
Processing of p105 Is Inhibited by Docking of p50 Active Subunits to the Ankyrin Repeat Domain, and Inhibition Is Alleviated by Signaling via the Carboxyl-terminal Phosphorylation/ Ubiquitin-Ligase Binding Domain
2001 StandoutNobel
EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function
2001 StandoutNobel
Autophagy in the Pathogenesis of Disease
2008 Standout
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
Systemic Lupus Erythematosus
2011 Standout
Autophagy in Human Health and Disease
2013 Standout
High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population
2018
Taking dendritic cells into medicine
2007 StandoutNatureNobel
Requirement of Non-canonical Activity of Uracil DNA Glycosylase for Class Switch Recombination
2006 StandoutNobel
Epstein–Barr virus: 40 years on
2004 Standout
Loss of autophagy in the central nervous system causes neurodegeneration in mice
2006 StandoutNature
Contrasting Roles of Dendritic Cells and B Cells in the Immune Control of Epstein-Barr Virus
2003
Tonsilar NK Cells Restrict B Cell Transformation by the Epstein-Barr Virus via IFN-γ
2008
Mechanisms and Functions of Inflammasomes
2014 Standout
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Molecular biology of Hodgkin's lymphoma
2002
A genetically humanized mouse model for hepatitis C virus infection
2011 StandoutNatureNobel
Expansion of EBV latent membrane protein 2a specific cytotoxic T cells for the adoptive immunotherapy of EBV latency type 2 malignancies: influence of recombinant IL12 and IL15
2003
Autophagy in immunity and inflammation
2011 StandoutNature
Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein–Barr virus nuclear antigen 1
1997 StandoutNobel
A Role for Intercellular Antigen Transfer in the Recognition of EBV-Transformed B Cell Lines by EBV Nuclear Antigen-Specific CD4+ T Cells
2006
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
Defective Control of Latent Epstein-Barr Virus Infection in Systemic Lupus Erythematosus
2004
The Class I Antigen-processing Pathway for the Membrane Protein Tyrosinase Involves Translation in the Endoplasmic Reticulum and Processing in the Cytosol
1998
Role of Cytotoxic T Lymphocytes in Epstein-Barr Virus-Associated Diseases
2000
The CD8+T-Cell Response to an Epstein-Barr Virus-Related Gammaherpesvirus Infecting Rhesus Macaques Provides Evidence for Immune Evasion by the EBNA-1 Homologue
2005
Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells
2014
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
The CD8+ Dendritic Cell Subset Selectively Endocytoses Dying Cells in Culture and In Vivo
2002 StandoutNobel
Epstein-Barr virus inhibits the development of dendritic cells by promoting apoptosis of their monocyte precursors in the presence of granulocyte macrophage–colony-stimulating factor and interleukin-4
2002
Identification of Virus-Encoded MicroRNAs
2004 StandoutScience
Inhibition of proteasomal degradation by the Gly-Ala repeat of Epstein–Barr virus is influenced by the length of the repeat and the strength of the degradation signal
2000
CD4+T-Cell Effectors Inhibit Epstein-Barr Virus-Induced B-Cell Proliferation
2001
Loss of EBNA1-specific memory CD4+ and CD8+ T cells in HIV-infected patients progressing to AIDS-related non-Hodgkin lymphoma
2005
Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1β production
2008 StandoutNature
Dendritic Cells Initiate Immune Control of Epstein-Barr Virus Transformation of B Lymphocytes In Vitro
2003 StandoutNobel
Evidence for the Presentation of Major Histocompatibility Complex Class I–restricted Epstein-Barr Virus Nuclear Antigen 1 Peptides to CD8+ T Lymphocytes
2004
Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis
2001 Standout
Processing and presentation of HLA class I and II epitopes by dendritic cells after transfection with in vitro–transcribed MUC1 RNA
2004
Activation of Natural Killer T Cells by α-Galactosylceramide Rapidly Induces the Full Maturation of Dendritic Cells In Vivo and Thereby Acts as an Adjuvant for Combined CD4 and CD8 T Cell Immunity to a Coadministered Protein
2003 StandoutNobel
Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells
2002 StandoutNobel
Modulation of Inflammasome Pathways by Bacterial and Viral Pathogens
2011
Dendritic Cells Cross-Present Latency Gene Products from Epstein-Barr Virus–Transformed B Cells and Expand Tumor-Reactive Cd8+ Killer T Cells
2001 StandoutNobel
Induction of autoimmune disease by deletion of CTLA-4 in mice in adulthood
2016 StandoutNobel
Epitope focusing in the primary cytotoxic T cell response to Epstein-Barr virus and its relationship to T cell memory.
1996
Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes
2005 StandoutNobel
Reconstitution of the Epstein-Barr virus–specific cytotoxic T-lymphocyte response following T-cell–depleted myeloablative and nonmyeloablative allogeneic stem cell transplantation
2003
Distinct memory CD4+ T-cell subsets mediate immune recognition of Epstein Barr virus nuclear antigen 1 in healthy virus carriers
2006
Dual Stimulation of Epstein-Barr Virus (EBV)-Specific CD4+- and CD8+-T-Cell Responses by a Chimeric Antigen Construct: Potential Therapeutic Vaccine for EBV-Positive Nasopharyngeal Carcinoma
2003
Endogenous Presentation of CD8+ T Cell Epitopes from Epstein-Barr Virus–encoded Nuclear Antigen 1
2004
Priming of protective T cell responses against virus-induced tumors in mice with human immune system components
2009 StandoutNobel
Differential regulation of S-region hypermutation and class-switch recombination by noncanonical functions of uracil DNA glycosylase
2014 StandoutNobel
Cytolytic CD4+-T-Cell Clones Reactive to EBNA1 Inhibit Epstein-Barr Virus-Induced B-Cell Proliferation
2003
Post-Transplant Lymphoproliferative Disorders
2004
Regulation of Adaptive Immunity by the Innate Immune System
2010 StandoutScience
Therapeutic LMP1 polyepitope vaccine for EBV-associated Hodgkin disease and nasopharyngeal carcinoma
2003
Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses
2008 StandoutNobel
Hepatitis C Virus Envelope Glycoprotein E1 Originates in the Endoplasmic Reticulum and Requires Cytoplasmic Processing for Presentation by Class I MHC Molecules
1999 StandoutNobel
Tolerogenic Dendritic Cells
2003 StandoutNobel
Human Cd4+ T Lymphocytes Consistently Respond to the Latent Epstein-Barr Virus Nuclear Antigen Ebna1
2000 StandoutNobel
The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction
2002 StandoutNobel
Antigen Presentation and T Cell Stimulation by Dendritic Cells
2002
HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation
2004 StandoutNobel
Functional Reversion of Antigen-Specific CD8+ T Cells from Patients with Hodgkin Lymphoma following In Vitro Stimulation with Recombinant Polyepitope
2006
Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses
2006 StandoutNobel
Cancer immunotherapy using checkpoint blockade
2018 StandoutScience
Innate or Adaptive Immunity? The Example of Natural Killer Cells
2011 StandoutScience
Immunization with Epstein-Barr Virus (EBV) peptide-pulsed dendritic cells induces functional CD8+ T-cell immunity and may lead to tumor regression in patients with EBV-positive nasopharyngeal carcinoma.
2002
Vaccinia Virus Uracil DNA Glycosylase Has an Essential Role in DNA Synthesis That Is Independent of Its Glycosylase Activity: Catalytic Site Mutations Reduce Virulence but Not Virus Replication in Cultured Cells
2002
Epstein-Barr Nuclear Antigen 1-Specific CD4+ Th1 Cells Kill Burkitt’s Lymphoma Cells
2002
Cellular Responses to Viral Infection in Humans: Lessons from Epstein-Barr Virus
2007
Mutation of the E6-AP Ubiquitin Ligase Reduces Nuclear Inclusion Frequency While Accelerating Polyglutamine-Induced Pathology in SCA1 Mice
1999 StandoutNobel
Works of Neil Blake being referenced
TAP-independent antigen presentation on MHC class I molecules: lessons from Epstein–Barr virus
2003
A case of primary immunodeficiency due to a defect of the major histocompatibility gene complex class I processing and presentation pathway
1997
Transporter (TAP)‐independent processing of a multiple membrane‐spanning protein, the Epstein‐Barr virus latent membrane protein 2
1996
Vaccinia virus serpins B13R (SPI-2) and B22R (SPI-1) encode Mr 38.5 and 40K, intracellular polypeptides that do not affect virus virulence in a murine intranasal model
1995
Human CD8 + T Cell Responses to EBV EBNA1: HLA Class I Presentation of the (Gly-Ala)–Containing Protein Requires Exogenous Processing
1997
Antigen Presenting Phenotype of Hodgkin Reed-Sternberg Cells: Analysis of the HLA Class I Processing Pathway and the Effects of Interleukin-10 on Epstein-Barr Virus-Specific Cytotoxic T-Cell Recognition
1998
Identification of a TAP-Independent, Immunoproteasome-Dependent CD8+T-Cell Epitope in Epstein-Barr Virus Latent Membrane Protein 2
2003
The Importance of Exogenous Antigen in Priming the Human CD8+ T Cell Response: Lessons from the EBV Nuclear Antigen EBNA1
2000
CD8 T Cell Recognition of Endogenously Expressed Epstein-Barr Virus Nuclear Antigen 1
2004
Differential Immunogenicity of Epstein-Barr Virus Latent-Cycle Proteins for Human CD4+T-Helper 1 Responses
2001
Inhibition of Antigen Presentation by the Glycine/Alanine Repeat Domain Is Not Conserved in Simian Homologues of Epstein-Barr Virus Nuclear Antigen 1
1999
Processing of a Multiple Membrane Spanning Epstein-Barr Virus Protein for Cd8+T Cell Recognition Reveals a Proteasome-Dependent, Transporter Associated with Antigen Processing–Independent Pathway
2001
Impaired recovery of Epstein-Barr virus (EBV)—specific CD8+ T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative disease
2003
Antigen Presenting Phenotype of Hodgkin Reed-Sternberg Cells: Analysis of the HLA Class I Processing Pathway and the Effects of Interleukin-10 on Epstein-Barr Virus-Specific Cytotoxic T-Cell Recognition
1998
B cells immortalized by a mini–Epstein-Barr virus encoding a foreign antigen efficiently reactivate specific cytotoxic T cells
2002